Peroxisome Proliferator-Activated Receptors Family Is Involved in the Response to Treatment and Mild Clinical Course in Patients with Ulcerative Colitis

Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

(2012) Luke Jostins et al.   NATURE

PPARγin Inflammatory Bowel Disease

(2012) Vito Annese et al.   PPAR Research

Activation of PPARγ and δ by dietary punicic acid ameliorates intestinal inflammation in mice

(2011) Josep Bassaganya-Riera et al.   BRITISH JOURNAL OF NUTRITION

Peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression is downregulated in patients with active ulcerative colitis

(2010) Jesús K. Yamamoto-Furusho et al.   INFLAMMATORY BOWEL DISEASES

PPARα contributes to colonic protection in mice with DSS-induced colitis

(2010) Yasu-Taka Azuma et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Correlations between RNA and protein expression profiles in 23 human cell lines

(2009) Marcus Gry et al.   BMC GENOMICS

A catalogue of reporting guidelines for health research

(2009) I. Simera et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-α MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE

(2009) Luisa Riccardi et al.   SHOCK

Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial

(2008) James D. Lewis et al.   GASTROENTEROLOGY